MF59-adjuvanted trivalent seasonal influenza vaccine compared to high-dose trivalent seasonal influenza vaccine among older adults, a systematic literature review

被引:0
|
作者
Dang, J. [1 ]
McGovern, I. [1 ]
Haag, M. [1 ]
Coleman, B. [2 ]
机构
[1] CSL Seqirus, Summit, NJ USA
[2] Univ Toronto, Publ Hlth, Toronto, ON, Canada
关键词
D O I
暂无
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
A81
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [41] High-dose trivalent influenza vaccine. Efficacy and effectiveness
    Gil de Miguel, Angel
    Redondo Marguello, Esther
    Diez Domingo, Javier
    Ortiz de Lejarazu, Raul
    Martinon Torres, Federico
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2020, 33 (04) : 226 - 239
  • [42] Better outcomes with high-dose trivalent influenza vaccine in seniors
    Machado, Marina A.
    Moura, Cristiano S.
    Abrahamowicz, Michal
    Ward, Brian J.
    Pilote, Louise
    Bernatsky, Sasha
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 88 - 89
  • [44] Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis
    Samson, Sandrine I.
    Leventhal, Phillip S.
    Salamand, Camille
    Meng, Ya
    Seet, Bruce T.
    Landolfi, Victoria
    Greenberg, David
    Hollingsworth, Rosalind
    EXPERT REVIEW OF VACCINES, 2019, 18 (03) : 295 - 308
  • [45] Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults
    Song, Joon Young
    Cheong, Hee Jin
    Tsai, T. F.
    Chang, Hyun-ah
    Choi, Min Joo
    Jeon, Ji Ho
    Kang, Seong Hee
    Jeong, Eun Ju
    Noh, Ji Yun
    Kim, Woo Joo
    VACCINE, 2015, 33 (36) : 4647 - 4652
  • [46] High-dose influenza vaccine in older adults by age and seasonal characteristics: Systematic review and meta-analysis update
    Lee, Jason K. H.
    Lam, Gary K. L.
    Yin, J. Kevin
    Loiacono, Matthew M.
    Samson, Sandrine I.
    VACCINE: X, 2023, 14
  • [47] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [48] Relative vaccine effectiveness of adjuvanted trivalent influenza vaccine compared to egg-based trivalent high dose and other egg-based vaccines
    Pelton, S.
    Postma, M.
    Divino, V.
    Mould, J.
    Dekoven, M.
    Krishnarajah, G.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 101 : 465 - 465
  • [49] Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥ 65 Years
    Kaka, Anjum S.
    Filice, Gregory A.
    Myllenbeck, Sharon
    Nichol, Kristin L.
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
  • [50] Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al
    Yin, J. Kevin
    Harris, Rebecca C.
    Loiacono, Matthew M.
    Chit, Ayman
    Samson, Sandrine I.
    VACCINE, 2023, 41 (27) : 3948 - 3948